Primary study · included by 1 review

Shen 2022

ProbableThe reviews cited this study without a PMID, DOI or NCT, so it is matched by first author and year. Two different studies by the same author in the same year could be merged here.

Included by

Diagnostic and Prognostic Significance of Chemokines in Head and Neck Cancers: A Systematic Review and Meta-Analysis.

Non-Cochrane · DTA;prognostic · 2026 · cited as Shen 2022 · Table 1; Figure 2-4

Outcome this study informs	Pooled effect	Evidence	Certainty
Overall survival High CXCR4 expression vs Low CXCR4 expression · Overall survival	HR 1.53 [0.55, 4.24]	4 studies	GRADE not reported

1 including review in total.